+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Successful pregnancy outcome with the use of antenatal high-dose intravenous immunoglobulin following previous neonatal death associated with neonatal haemochromatosis



Successful pregnancy outcome with the use of antenatal high-dose intravenous immunoglobulin following previous neonatal death associated with neonatal haemochromatosis



Australian and New Zealand Journal of Obstetrics and Gynaecology 50(4): 403-405




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055998329

Download citation: RISBibTeXText

PMID: 20716273

DOI: 10.1111/j.1479-828x.2010.01181.x


Related references

High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 364(9446): 1690-1698, 2004

High-dose immunoglobulin during pregnancy for two patients with risk of recurrent neonatal haemochromatosis. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 36(4): 409-412, 2007

Successful pregnancy outcome following maternal intravenous immunoglobulin treatment in a woman with recurrent perinatal haemochromatosis. Prenatal Diagnosis 26(13): 1256-1259, 2006

Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics 121(6): E1615, 2008

Transient neonatal liver disease after maternal antenatal intravenous Ig infusions in gestational alloimmune liver disease associated with neonatal haemochromatosis. Journal of Pediatric Gastroenterology and Nutrition 59(5): 629-635, 2014

Antenatal fetal therapy for neonatal allo-immune thrombocytopenia with high dose immunoglobulin. British Journal of Obstetrics and Gynaecology 101(11): 1011-1013, 1994

High-dose immunoglobulin in the antenatal treatment of neonatal alloimmune thrombocytopenia: case report and review. British Journal of Obstetrics and Gynaecology 99(3): 260-262, 1992

The Japanese experience and pharmacokinetics of antenatal maternal high-dose immunoglobulin treatment as a prophylaxis for neonatal hemochromatosis in siblings. Journal of Maternal-Fetal and Neonatal Medicine 33(1): 142-148, 2020

Failure of antenatal high-dose immunoglobulin to improve fetal platelet count in neonatal allo-immune thrombocytopenia. Vox Sanguinis 55(3): 188-189, 1988

High-dose intravenous immunoglobulin in transient neonatal myasthenia gravis. Pediatric Neurology 18(2): 181-183, 1998

High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatrica 89(3): 371-372, 2000

Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease. Journal of Perinatal Medicine 23(6): 443-451, 1995

Neonatal autoimmune thrombocytopenia: role of high-dose intravenous immunoglobulin G therapy. Blut 59(1): 139-144, 1989

High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatrica 88(2): 216-219, 1999

High-dose intravenous immunoglobulin in the prenatal management of neonatal alloimmune thrombocytopenia. Clinical and Laboratory Haematology 13(1): 75-79, 1991